5 Mass General Brigham innovation projects awarded funding

Five Mass General Brigham innovation projects seeking to improve treatment for patients with challenging diseases were awarded funding Jan. 6 through the Boston-based health system’s Innovation Discovery Grants program. 

Advertisement

Each project will receive $100,000. The Innovation Discovery Grants program has distributed more than $3.5 million in grants since its inception in 2014.

Below is an overview of the five innovation projects that received grants:

  1. Brain Penetrant AAV Vectors for CNS Gene Therapy: Fengfeng Bei, PhD, a principal investigator at Brigham and Women’s Hospital’s neurosurgery department, is leading a project seeking to optimize adeno-associated virus gene delivery technology to strengthen its ability to treat diseases in the central nervous system.
  2. Commensal Papillomavirus Vaccine Development for Skin Cancer Therapy: Shawn Demehri, MD, PhD, a principal investigator at Massachusetts General Hospital’s Center for Cancer Immunology and Cutaneous Biology Research, is leading a project to use an HPV vaccine strategy to treat squamous cell carcinoma.
  3. Harnessing Neutrophil Plasticity for the Treatment of Cancer: Tanya Mayadas, PhD, a senior scientist at Brigham and Women’s Hospital’s pathology department, is leading a project seeking to improve cancer treatment by activating T cells through an antigen-antibody conjugate.
  4. A Clinically Applicable AI Toolbox for Dystonia Diagnosis: Kristina Simonyan, MD, PhD, the director of laryngology research at Massachusetts Eye and Ear, is leading a project focusing on developing a machine learning model for automatic dystonia diagnosis.
  5. Addressing the Need for Early, Accurate Diagnosis of Parkinson’s Disease: A New PET Radiotracer: Anna Sromek, PhD, the associate director of McLean Hospital’s medicinal chemistry laboratory, is leading a project to discover a reliable biomarker or imaging technique to accurately diagnose Parkinson’s disease earlier.

More articles on digital transformation:
Genomics company Color gains unicorn status
5 recent health IT, innovation partnerships
Why CIOs are gaining more influence in front-office decision making in 2021 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

What clinicians need from AI after the pilot: Lessons from Adventist Health and Rady Children’s

Friday, July 24
12:00 PM - 1:00 PM CDT

Presenters: Dr. Dieter Sumerauer, Rady Children’s HealthDr. Salman Naqvi, AdventistDr. Reid Conant, Abridge

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.